A nationwide survey by the Alzheimer’s Association in 2025 found close to 4 in 5 Americans 45 and older want to know if they have Alzheimer’s before symptoms appear. And 91% said they would take a ...

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: ...

Long COVID can linger long after the acute infection ends. People report fatigue, brain fog, dizziness, and poor sleep. Many ...

Ropar have unveiled a cutting-edge diagnostic approach that could transform how bacterial infections are identified in ...

In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

In parallel with the tendered offer, PathoCare Holdings announced that-based on stronger-than-expected institutional interest and market demand-the Company is increasing the size of its contemplated ...

At Health First, this innovation is being brought to life through partners like NextGen Pathology, delivering precise diagnostic services.

Learn more about whether Charles River Laboratories International, Inc. or Illumina, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...

The meeting focused on public health system strengthening, patient-centric care, regulatory oversight, diagnostic services, ...

Learn more about whether Charles River Laboratories International, Inc. or Thermo Fisher Scientific Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key ...

The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.